Aesthetic Plastic Surgery

, Volume 33, Issue 4, pp 544–548 | Cite as

Injectable Calcium Hydroxylapatite for Correction of Nasal Bridge Deformities

  • Horia R. SiclovanEmail author
  • Jamal A. Jomah
Original Article



Minimally invasive procedures for aesthetic surgery have become widely popular, and facial soft tissue augmentation is one of the most common procedures. Various kinds of fillers have been used, and recently the use of calcium hydroxylapatite was extended to cosmetic facial procedures. This article presents the authors’ experience with primary and secondary nasal bridge correction using calcium hydroxylapatite (Radiesse).


This preliminary prospective study investigated the use of commercially available calcium hydroxylapatite (Radiesse) for correction of nasal bridge deformities. Calcium hydroxylapatite was injected on the plane of the periosteum in a retrograde fashion using a linear, threading, fanning, or crosshatching technique. The patients were followed for several months, with the outcome and side effects assessed both subjectively and objectively.


Patients showed a persistence of benefit up to 1 year during the follow-up period, with pleasing long-term results.


Calcium hydroxylapatite (Radiesse) is a useful injectable filler for correction of nasal bridge deformities. Further efficacy studies seem justified.


Calcium hydroxylapatite Nasal bridge correction Radiesse 


  1. 1.
    Busso M, Karlsberg PL (2006) Check augmentation and rejuvenation using injectable calcium hydroxylapatite (Radiesse). Cosmet Dermatol 19:583Google Scholar
  2. 2.
    Carruthers A, Liebeskind B, Carruthers J, Forster BB (2008) Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds. Dermatol Surg 34(Suppl 1):S78–S84Google Scholar
  3. 3.
    Felderman LI (2005) Radiesse for facial rejuvenation. Cosmet Dermatol 18:823Google Scholar
  4. 4.
    Goldberg DJ (2006) Calcium hydroxylapatite: fillers in cosmetic dermatology. Informa UK Ltd, Abingdon, EnglandGoogle Scholar
  5. 5.
    Graivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL (2007) Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg 120(Suppl):55S–66SGoogle Scholar
  6. 6.
    Hubbard W (2002) BioForm implants: durability. Bioform, Inc, FranksvilleGoogle Scholar
  7. 7.
    Hubbard W (2003) BioForm implants: biocompatibility. Bioform, Inc, FranksvilleGoogle Scholar
  8. 8.
    Jansen DA, Graivier MH (2006) Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft tissue augmentation. Plast Reconstr Surg 118(Suppl.):22SGoogle Scholar
  9. 9.
    Jones JK (2006) Patient safety considerations regarding dermal filler injections. Plast Surg Nurs 26:156PubMedGoogle Scholar
  10. 10.
    Marmur ES, Phelps R, Goldberg DJ (2004) Clinical, histologic, and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther 6:223PubMedCrossRefGoogle Scholar
  11. 11.
    Tzikas TL (2004) Evaluation of Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg 6:234PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery 2008

Authors and Affiliations

  1. 1.Med Art ClinicsRiyadhSaudi Arabia

Personalised recommendations